why choose us

First received: October 17, 2023

Clinical Trial: A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Subjects

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-Label, Parallel Group, Phase 1 Study to Assess the Pharmacodynamic Effect of AP301 on Urinary Phosphorus Excretion in Healthy Volunteers

Brief Summary: This is a randomized, open-label, parallel-group, phase 1 study to evaluate the PD effect of AP301 capsule in healthy volunteers.The study is planned to have 4 treatment arms: Arm 1: 2.10 g/day; arm 2: 4.20 g/day; arm 3: 6.30 g/day; arm 4: 8.40 g/day.

Read more